Cryoport, Inc. — Director's Dealing 2021

Aug 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2021-08-11

Reporting Person: Sawicki Mark W (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-11	Common Stock	M	77625	$7.80	Acquired	113698	Direct
2021-08-11	Common Stock	M	16577	$8.65	Acquired	130275	Direct
2021-08-11	Common Stock	S	74453	$58.3740	Disposed	55822	Direct
2021-08-11	Common Stock	S	3172	$59.1149	Disposed	52650	Direct
2021-08-11	Common Stock	S	2521	$59.8338	Disposed	50129	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-11	Option to purchase common stock	$7.80	M	77625	Disposed	2025-05-07	Common Stock (77625)	Direct
2021-08-11	Option to purchase common stock	$8.65	M	16577	Disposed	2028-03-28	Common Stock (16577)	Direct

Footnotes

F1: 1/48 of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015.

F2: 1/48 of the 68,000 options originally granted vested on the 28th of each month for forty-eight months beginning April 28, 2018.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.85 to $58.84, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.85 to $59.51, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.81 to $59.90, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.